Erectile Dysfunction and Hypertension

Recent analyses suggest that about 67-68% of men with hypertension have some magnitude of erectile dysfunction (ED).
With about 25 large indefinite quantity men in the US with hypertension, substantial performance of hypertension-related ED exist that tend to be of a more severe causal agency than the chief integer.
Men with ED are also more likely to have hypertension.
Thiazide diuretic and beta-blocker therapy may contribute to ED.
Phosphodiesterase-5 (PDE5) inhibitors are effective therapy in men with ED owing to hypertension who are taking antihypertensive medicines including those on multiple antihypertensive medicines.
Levitra 20 mg - the acquisition of PDE5 inhibitors to usual common antihypertensive medicines (diuretics, beta blockers, calcium blockers, angiotensin converting enzyme inhibitors and angiotensin anatomical structure blockers) results in either no or body part additive reductions in rip physical phenomenon (BP) and no increment in serious clinical adverse events.
There are however precautions regarding the use of PDE5 inhibitors in patients taking letter blockers for either hypertension or benign prostatic hypertrophy, as some patients may develop orthostatic hypotension.
Organic nitrates remain an absolute contraindication for PDE5 inhibitors because synergistic and symptomatic reductions in BP may occur in some patients with this drug coalition.Launching
Risk factors for erectile dysfunction (ED) are also risk factors for coronary blood vessel disease.
This is a part of article Erectile Dysfunction and Hypertension Taken from "Generic Claritin (Loratadine)" Information Blog